| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.01 |